As a result of approving this indication, Sigmart injection is considered to offer a new therapeutic option to patients who need intravenous administration of vasodilators.
Sigmart injection is an anti-unstable anginal drug that concomitantly has a nitrate like action and ATP-sensitive potassium channel opening action.